Albert Bourla

Bourla disahkan positif kali pertama Ogos lalu dan telah menerima rawatan antiviral COVID-19 Paxlovid.

Ketua Pegawai Eksekutif Pfizer Inc. Albert Bourla mendedahkan beliau disahkan positif COVID-19 dan sedang menerima rawatan menggunakan ubat antiviral Paxlovid dihasilkan syarikatnya.

The vaccine was found to elicit a strong immune response following a third dose, and was well tolerated by the children.

Some patients have reported that COVID-19 symptoms recurred after completing treatment and experiencing improvement.

Second booster shots are currently recommended in some countries for only a subset of the population.

WHO "strongly recommended" Pfizer's Paxlovid for patients with milder forms of the disease who were still at a high risk of hospitalisation.

The firm is also working on producing a vaccine that could provide good protection for a whole year.

The American drugmaker said its treatment, called Paxlovid, withstood the Omicron variant in lab-testing.

The study presented the "first results" of a booster trial, with a third shot of the vaccine demonstrating a "favourable safety profile".

Innoculating children is also seen as key to keeping schools open and helping end the pandemic.

Biden cast the donation as a bold move that shows America recognises its responsibility to the world and to its own citizens.

A rundown of the most important stories you need to know for the day, from the newsroom of Astro AWANI.

Syarikat farmaseutikal Pfizer sedang memantau varian COVID-19 baharu yang berasal dari India.

Khairy menjelaskan buat masa ini kerajaan belum memutuskan tentang dos ketiga namun akan membuat perancangan jangka masa panjang berkenaan perkara berkenaan.

Kessler said while the duration of immunity after vaccination is being studied, booster vaccines could be needed.